Direktorat Registrasi ObatValid

TAMIVELL

BPOM Number: DKL2433557443B1
Approved: 21 November 2024
Expiry: 15 March 2029
Form: INJEKSI; 57,67 MG

About This Registration

TAMIVELL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2433557443B1. Its current registration status is Valid, with the licence valid until 15 March 2029. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in March 2024. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 VIAL @ 10 ML
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
NPWP: 010026805052000
owner
View profile →

Manufacturing Sites

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
primary
View profile →

Ingredients (1)

KETAMINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Registration Age: Registered for 2 years, 6 months